ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Screening tests for occlusive vascular syndromes

Screening tests for occlusive vascular syndromes
Complete blood count with differential, platelet count, and blood smear
Polycythemia or anemia, granulocytosis, thrombocytosis, poikilocytosis
  • May be a sign of myeloproliferative or myelodysplastic diseases
Evidence of red cell fragmentation (schistocytes) and microangiopathy, consider:
  • TTP-hemolytic uremic syndrome
  • Purpura fulminans with DIC, occasionally
  • Antiphospholipid antibody syndrome, occasionally
Thrombocytopenia, consider:
  • Heparin necrosis, some patients
  • Purpura fulminans with DIC
  • TTP-hemolytic uremic syndrome
  • Antiphospholipid antibody syndrome, some patients
Severe neutropenia
  • Immunocompromised; opportunistic infections very likely
Eosinophilia
  • Cholesterol emboli
Partial thromboplastin time
Minimally prolonged in TTP-hemolytic uremic syndrome
Prolonged in purpura fulminans and DIC
Prolonged if lupus anticoagulant activity present, and assay sensitive
Cryoglobulins (occasionally cryofibrinogen and cold agglutinins) when location and history suggest cold occlusion syndrome
Biopsy
Confirms occlusion versus other mechanisms of vessel injury
May suggest platelet plugs instead of fibrin thrombi
May suggest cryoglobulin gelling
May diagnose calciphylaxis
May suggest cholesterol, oxalate, or crystal globulin occlusion
Special stains for organisms in immunocompromised hosts, when appropriate
Basic hepatic and renal function screens
Hepatic function can affect vitamin K-dependent factors and warfarin metabolism
Renal disease moves cutaneous calciphylaxis higher in the differential diagnosis
ANCA
To reduce the likelihood of the uncommon noninflammatory retiform purpura presentation of granulomatosis with polyangiitis (Wegener's granulomatosis) or microscopic polyangiitis
ANCA may be available before permanent histologic sections
TTP: thrombotic thrombocytopenic purpura; DIC: disseminated intravascular coagulation; ANCA: antineutrophil cytoplasmic antibody.
Reproduced from: Cutaneous manifestations of microvascular occlusion syndromes. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, Spain 2008. Table used with the permission of Elsevier Inc. All rights reserved.
Graphic 62872 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟